Crystal structure of bisoprolol fumarate Form I, (C18H32NO4) (C4H2O4)0.5

被引:1
|
作者
Kaduk, James A. [1 ,2 ]
Gindhart, Amy M. [3 ]
Blanton, Thomas N. [3 ]
机构
[1] IIT, 3101 S Dearborn St, Chicago, IL 60616 USA
[2] North Cent Coll, 131 S Loomis St, Naperville, IL 60540 USA
[3] ICDD, 12 Campus Blvd, Newtown Sq, PA 19073 USA
关键词
bisoprolol fumarate; Zebeta; powder diffraction; Rietveld refinement; density functional theory; DIFFRACTION; VALIDATION; PATTERNS; DENSITY;
D O I
10.1017/S0885715619000757
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
The crystal structure of bisoprolol fumarate Form I has been solved and refined using synchrotron X-ray powder diffraction data and optimized using density functional techniques. Bisoprolol fumarate Form I crystallizes in space group P-1 (#2) with a = 8.165 70(5) angstrom, b = 8.516 39(12) angstrom, c = 16.751 79(18) angstrom, alpha = 89.142(1)degrees, beta = 78.155(1)degrees, gamma = 81.763(1)degrees, V = 1128.265(10) angstrom(3), and Z = 2. The neutral side chain of the bisoprolol cation is probably disordered. The cation and anion are linked by N-H center dot center dot center dot O and O-H center dot center dot center dot O hydrogen bonds. The cations are also linked by N-H center dot center dot center dot O hydrogen bonds. The result is alternating layers of hydrophilic and hydrophobic layers parallel to the ab-plane. The density of the structure is relatively low at 1.130 g cm(-3), but there are no obvious voids in the structure. The powder pattern is included in the Powder Diffraction File (TM) as entry 00-066-1625. (C) 2019 International Centre for Diffraction Data.
引用
收藏
页码:34 / 40
页数:7
相关论文
共 50 条
  • [41] Crystal structures of lanthanide terephthalate tetrahydrate, R2(C8H4O4)3(H2O)4, R = La-Er
    Markun, Emma L.
    Kaduk, James A.
    POWDER DIFFRACTION, 2022, 37 (01) : 2 - 12
  • [42] Theoretical study on the reaction of butadiynyl radical (C4H) with ethylene (C2H4) to form C6H4 and H
    Kim, Joonghan
    Ihee, Hyotcherl
    INTERNATIONAL JOURNAL OF QUANTUM CHEMISTRY, 2012, 112 (08) : 1913 - 1925
  • [43] Crystal structure of ziprasidone hydrochloride monohydrate, C21H22Cl2N4OS(H2O)
    Kaduk, James A.
    Zhong, Kai
    Gindhart, Amy M.
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2015, 30 (03) : 192 - 198
  • [44] Crystal structure of bumetanide, C17H20N2O5S
    Diulus, Samantha C.
    Kaduk, James A.
    Gindhart, Amy M.
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2019, 34 (02) : 189 - 195
  • [45] Crystal structure of alectinib hydrochloride Type I, C30H35N4O2Cl
    Kaduk, James A.
    Rost, Megan M.
    Dosen, Anja
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2024, 39 (03) : 170 - 175
  • [46] Crystal structure of anthraquinone-2-carboxylic acid, C15H8O4
    Ens, Tawnee M.
    Kaduk, James A.
    Dosen, Anja
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2024, 39 (01) : 29 - 35
  • [47] Crystal structure of atorvastatin calcium trihydrate Form I (Lipitor®), (C33H34FN2O5)2Ca(H2O)3
    Hodge, Ryan L.
    Kaduk, James A.
    Gindhart, Amy M.
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2020, 35 (02) : 136 - 143
  • [48] Crystal structure of minocycline hydrochloride dihydrate form A, C23H28N3O7Cl (H2O)2
    Wheatley, Austin M.
    Kaduk, James A.
    Gindhart, Amy M.
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2019, 34 (01) : 59 - 65
  • [49] Crystal Structure of Fosfomycin Tromethamine, (C4H12NO3)(C3H6O4P), from Synchrotron Powder Diffraction Data and Density Functional Theory
    Butler, Zachary R.
    Kaduk, James A.
    Gindhart, Amy M.
    Blanton, Thomas N.
    CRYSTALS, 2019, 9 (08):
  • [50] Crystal structure of ipratropium bromide monohydrate, C20H30NO3Br(H2O)
    Bhaskar, Shivang
    Golab, Joseph T.
    Kaduk, James A.
    Gindhart, Amy M.
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2020, 35 (01) : 61 - 66